Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 317 JPY -0.15% Market Closed
Market Cap: 32B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fuji Pharma Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Cash & Cash Equivalents
ÂĄ2.7B
CAGR 3-Years
-34%
CAGR 5-Years
-18%
CAGR 10-Years
-10%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash & Cash Equivalents
ÂĄ804.3B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
3%
Daiichi Sankyo Co Ltd
TSE:4568
Cash & Cash Equivalents
ÂĄ805.3B
CAGR 3-Years
32%
CAGR 5-Years
25%
CAGR 10-Years
17%
Otsuka Holdings Co Ltd
TSE:4578
Cash & Cash Equivalents
ÂĄ485.9B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash & Cash Equivalents
ÂĄ462.9B
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
16%
Astellas Pharma Inc
TSE:4503
Cash & Cash Equivalents
ÂĄ302.9B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
-2%

See Also

What is Fuji Pharma Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.7B JPY

Based on the financial report for Jun 30, 2024, Fuji Pharma Co Ltd's Cash & Cash Equivalents amounts to 2.7B JPY.

What is Fuji Pharma Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-10%

Over the last year, the Cash & Cash Equivalents growth was -32%. The average annual Cash & Cash Equivalents growth rates for Fuji Pharma Co Ltd have been -34% over the past three years , -18% over the past five years , and -10% over the past ten years .

Back to Top